Kolon Life Science Inc

Chart & Performance

D1W1MN

P/E

—

P/S

2.13

EPS

—

Div Yield, %

0.00%

Shrs. gr., 5y

—

Rev. gr., 5y

4.16%

Revenues

124.64b

-22.86%

Net income

-30.73b

CFO

-24.87b

L+19.24%

Earnings

Feb 12, 2025

URL

IPO date

Apr 07, 2009

Employees

Domiciled in

Incorporated in

Title KRW in thousands, except ratios and share amounts	FY	FY	FY	FY	FY
Title KRW in thousands, except ratios and share amounts	2023‑12	2022‑12	2021‑12	2020‑12	2019‑12
Income
Revenues	124,639,035 -22.86%	161,583,790 -2.36%
Cost of revenue	138,583,768	149,785,802
Unusual Expense (Income)
NOPBT	(13,944,733)	11,797,987
NOPBT Margin		7.30%
Operating Taxes	1,253	107,928
Tax Rate		0.91%
NOPAT	(13,945,986)	11,690,060
Net income	(30,726,340) -1,540.31%	2,133,315 -255.16%
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current	97,691,038	73,748,948
Long-term debt	10,791,555	621,990
Deferred revenue		3,448,428
Other long-term liabilities	33,250,569	23,441,292
Net debt	23,867,376	(7,240,579)
Cash flow
Cash from operating activities	(24,865,565)	(20,853,663)
CAPEX	(10,143,646)	(6,307,562)
Cash from investing activities	(7,025,958)	(5,936,554)
Cash from financing activities	32,889,280	5,457,612
FCF	(9,972,747)	(11,398,019)
Balance
Cash	7,561,343	6,371,342
Long term investments	77,053,874	75,240,175
Excess cash	78,383,265	73,532,327
Stockholders' equity	(127,582,641)	(41,390,944)
Invested Capital	406,367,783	309,543,687
ROIC		4.02%
ROCE		4.25%
EV
Common stock shares outstanding	12,639	13,088
Price	25,700.00 -6.20%	27,400.00 -36.65%
Market cap	324,832,143 -9.42%	358,606,295 -27.03%
EV	348,699,519	351,365,717
EBITDA	(5,114,033)	21,265,167
EV/EBITDA		16.52
Interest	5,857,166	3,722,083
Interest/NOPBT		31.55%